Spectral AI Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	less than a year
Board average tenure	1.1yrs

Recent management updates

Recent updates

Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 43% Price Jump

Nov 03

Slammed 25% Spectral AI, Inc. (NASDAQ:MDAI) Screens Well Here But There Might Be A Catch

Sep 19

Analysts Have Been Trimming Their Spectral AI, Inc. (NASDAQ:MDAI) Price Target After Its Latest Report

Aug 15

Cautious Investors Not Rewarding Spectral AI, Inc.'s (NASDAQ:MDAI) Performance Completely

Jun 28

Many Still Looking Away From Spectral AI, Inc. (NASDAQ:MDAI)

Dec 27

CEO

Spectral AI has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Wensheng Fan	Co-Founder	less than a year	US$1.35m	0.19% $ 40.3k
Vincent Capone	CFO, General Counsel & Corporate Secretary	2.7yrs	US$527.88k	0.11% $ 22.8k
Christine Marks	Vice President of Marketing & Commercialization	2.6yrs	US$372.67k	no data
Erich Spangenberg	CEO of Health care & Director	less than a year	US$16.53k	25.86% $ 5.5m
John DiMaio	Founder & Chairman	less than a year	no data	13.46% $ 2.9m
Stan Micek	Interim Chief Operating Officer	less than a year	no data	0.054% $ 11.6k
Paul Chadwick	Executive Vice President of UK & EMEA	1.1yrs	no data	no data
Jeremiah Sparks	Chief Commercialization Officer	less than a year	no data	0.087% $ 18.6k
David Bronson	Financial Controller	no data	no data	no data

0.9yrs

Average Tenure

59.5yo

Average Age

Experienced Management: MDAI's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Erich Spangenberg	CEO of Health care & Director	less than a year	US$16.53k	25.86% $ 5.5m
John DiMaio	Founder & Chairman	less than a year	no data	13.46% $ 2.9m
John Botts	Member of Advisory Board	no data	no data	no data
Delos Cosgrove	Member of Advisory Board	no data	no data	no data
Richard Cotton	Lead Independent Director	3.4yrs	US$121.25k	0.26% $ 55.1k
Martin Mellish	Independent Director	3.4yrs	US$125.78k	no data
Marion Snyder	Director	less than a year	no data	no data
Deepak Sadagopan	Independent Director	1.2yrs	US$10.00k	no data

1.1yrs

Average Tenure

67yo

Average Age

Experienced Board: MDAI's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.

Spectral AI Management

Management criteria checks 0/4

Key information

Recent management updates

Spectral AI Announces Management Changes for Spectral IP (to be Renamed SIM IP Inc.)

Spectral AI, Inc. Announces Board Changes

Spectral AI, Inc. Appoints Erich Spangenberg CEO of Spectral IP, Its Health Care IP-Focused Subsidiary

Spectral AI, Inc., Annual General Meeting, May 14, 2024

Spectral AI, Inc. Announces the Appointment of Jeremiah A. Sparks as Chief Commercialization Officer

Spectral AI, Inc. Announces Board Changes

Recent updates

Spectral AI Announces DeepView SnapShot M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research

Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $2.2701 million.

Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $2.2701 million.

Consensus estimates of losses per share improve by 19%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

New minor risk - Profitability

Spectral AI Announces Management Changes for Spectral IP (to be Renamed SIM IP Inc.)

Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 43% Price Jump

Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers

Spectral AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Spectral AI, Inc. Announces Board Changes

Spectral AI, Inc. Completes Proof of Concept for Wound Measurement Technology

New minor risk - Share price stability

Slammed 25% Spectral AI, Inc. (NASDAQ:MDAI) Screens Well Here But There Might Be A Catch

Spectral AI, Inc. Outlines U.S. Regulatory Pathway for Deepview System for Burn Indication

Spectral AI, Inc. Completes Burn Center Enrollment for U.S. Burn Pivotal Study

New minor risk - Share price stability

Analysts Have Been Trimming Their Spectral AI, Inc. (NASDAQ:MDAI) Price Target After Its Latest Report

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Spectral Ai, Inc. Reiterates Revenue Guidance for Fiscal Year 2024

Spectral AI, Inc. Announces Continuing Progress in Development of Handheld Deepview Snapshot M®? for Military Field Use

Spectral AI, Inc. to Report Q2, 2024 Results on Aug 12, 2024

Spectral AI, Inc. Adds Three New Clinical Trial Sites to Expedite Emergency Department Patient Enrollment

Price target decreased by 8.9% to US$5.65

Spectral AI, Inc. Expands Clinical Trial Sites for Pivotal U.S. Burn Study

Spectral Ai Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study

Cautious Investors Not Rewarding Spectral AI, Inc.'s (NASDAQ:MDAI) Performance Completely

Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Spectral AI, Inc. Reiterates Revenue Guidance for the Year 2024

Spectral AI, Inc. to Report Q1, 2024 Results on May 07, 2024

Spectral AI, Inc. Appoints Erich Spangenberg CEO of Spectral IP, Its Health Care IP-Focused Subsidiary

Spectral AI, Inc., Annual General Meeting, May 14, 2024

Spectral AI, Inc. Announces the Appointment of Jeremiah A. Sparks as Chief Commercialization Officer

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Spectral AI, Inc. announced that it expects to receive $30 million in funding

Spectral AI, Inc. to Report Q4, 2023 Results on Mar 27, 2024

Spectral AI, Inc. Receives UKCA Authorization for Burn Indication Expected Commercialization Second Half 2024

Spectral AI, Inc. Announces Board Changes

Spectral AI, Inc. Announces Resignation of Michael Murphy as Director

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI for Burn Injuries

Spectral AI, Inc. announced that it expects to receive $10 million in funding from B. Riley Principal Capital II, LLC

Spectral AI, Inc. announced that it expects to receive $10 million in funding from B. Riley Principal Capital II, LLC

Many Still Looking Away From Spectral AI, Inc. (NASDAQ:MDAI)

Spectral AI, Inc. Announces Chief Financial Officer Changes

Spectral AI, Inc. Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

Spectral AI, Inc. Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

Third quarter 2023 earnings released: US$0.77 loss per share (vs US$0.008 loss in 3Q 2022)

Spectral AI, Inc. to Report Q3, 2023 Results on Nov 13, 2023

New major risk - Financial position

Spectral AI, Inc. Provides Revenue Guidance for Fiscal Year 2024

Spectral AI, Inc. Provides Revenue Guidance for Fiscal Year 2024

Spectral AI's DeepView SnapShot(R) Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification

Spectral Ai, Inc. Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer Study

Spectral Ai, Inc. Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer Study

Spectral AI, Inc. Appoints Deepak Sadagopan, MHCDS, to Its Board of Directors

High number of new and inexperienced directors

CEO

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age